Literature DB >> 14405676

Antirabic immunity in guinea-pigs induced by high egg passage Flury virus. The influence of the route of administration on the resistance to cerebral and extraneural challenge.

C HUYGELEN.   

Abstract

Entities:  

Keywords:  RABIES/immunology

Mesh：

Substances：

Year:  1960        PMID： 14405676      PMCID： PMC2134346          DOI： 10.1017/s0022172400038262

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN： 0022-1724


× No keyword cloud information.
  7 in total

1.  [Titration of rabies vaccine produced with the Flury strain].

Authors:  V MATEWA
Journal:  Zentralbl Bakteriol Orig       Date:  1959-05

2.  Attempts to immunize guinea pigs with Flury vaccine and subsequent challenge with fixed rabies virus.

Authors:  C HUYGELEN; J MORTELMANS
Journal:  Am J Vet Res       Date:  1959-01       Impact factor: 1.156

3.  [Control of the immunizing power of antirabies vaccine by means of guinea pigs].

Authors:  B CASTAGNOLI; Z ORFEI
Journal:  Rend Ist Sup Sanit       Date:  1955

4.  Studies on chick-embryo-adapted rabies virus. VII. Immunological responses of animals to vaccination with high egg passage Flury strain.

Authors:  H KOPROWSKI; J BLACK
Journal:  J Immunol       Date:  1954-06       Impact factor: 5.422

5.  Studies on chick-embryo-adapted-rabies virus. VI. Further changes in pathogenic properties following prolonged cultivation in the developing chick embryo.

Authors:  H KOPROWSKI; J BLACK; D J NELSEN
Journal:  J Immunol       Date:  1954-01       Impact factor: 5.422

6.  Studies on chick-embryo-adapted rabies virus. IV. Immunization of guinea-pigs and description of a potency control test.

Authors:  H KOPROWSKI; J BLACK
Journal:  J Immunol       Date:  1954-01       Impact factor: 5.422

7.  Studies on chick-embryo adapted rabies virus. II. Pathogenicity for dogs and use of egg-adapted strains for vaccination purposes.

Authors:  H KOPROWSKI; J BLACK
Journal:  J Immunol       Date:  1950-03       Impact factor: 5.422
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.